FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
26/02/2024
Voltar para busca
Dado oficial do USPTO
SEFIRA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
26/02/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5
Data de depósito
24/11/2021
Data de registro
31/10/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
31/10/2023
Última transação
31/10/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
85
Localização do titular
CH
Examinador
RIEPEL, CHRISTINA MAXINE
Unidade examinadora
N60
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized wording SEFIRA and a design comprising two intersecting oblongs.
Titulares e representantes
Titulares
Sutara SA
Representantes
Yue (Robert) Xu Apex Attorneys at Law, LLP
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceuticalsantibiotics; diagnostic preparations for medical and veterinary use; sanitary preparations for medical purposes; dietetic food and preparations adapted for medical or veterinary usefood for babies; dietary supplements for human beings and animals; plastersmaterials for medical dressings; disinfectants; adjuvants for medical purposes; cooling sprays for medical purposes; albumin dietary supplements; alginate dietary supplements; amino acids for medical purposes; amino acid preparations for medical purposes; analgesics; anaesthetics; vermifuges; anti-uric preparations; antibacterial pharmaceuticals; antiseptics; autonomic drugs for medical purposes in treating diseases or disorders related to the parasympathetic nervous system; germicides; balms for medical purposes; balsamic preparations for medical purposes; albuminous preparations being dietetic foods for medical purposes; albuminous foodstuffs for medical purposes; activated charcoal dietary supplements; biological preparations for medical purposes for the treatment of cancer; bronchodilating preparations; vaccines; vitamin preparations; vitamin and mineral preparations for medical use; lead waterdietetic beverages for treating heavy metal poisoning; mineral waters for medical purposes; dietary fibre for use as a dietary supplement; herbal remediesherbal extracts for medical purposes; homogenized food adapted for medical purposes; disinfectants for hygiene purposes; diagnostic preparations for medical purposes; dietary supplements; nutritional and dietary supplements for stress relief; antioxidants being dietary supplements; anti-cancer preparations; nutritional and dietary supplements for strengthening the immune system; dietary supplements intended to supplement a normal diet or to have health benefits; dietary supplements consisting of vitamins; royal jelly dietary supplements; glucose dietary supplements; pollen dietary supplements; dietary supplements with a cosmetic effect; linseed dietary supplements; linseed oil dietary supplements; acai powder dietary supplements; propolis dietary supplements; wheat germ dietary supplements; natural dietary supplements for treatment of claustrophobia; dietetic beverages adapted for medical purposes; dietetic preparations adapted for medical use; dietetic foods adapted for medical purposes; yeast dietary supplements; plant extracts for pharmaceutical purposes; herbal extracts for medical purposes; elixirs being pharmaceutical preparations for treatment of headache; enzyme dietary supplements; febrifuges; carbohydrate-based dietary supplements; blood substitutes for medical or veterinary purposes; nervines being medicines for treatment of nerve disorders; drugs for medical purposes in the treatment of nervous system disorders; recombinant drug-metabolizing enzyme being biochemical preparations for veterinary purposes; immunostimulants; casein dietary supplements; amino acids for pharmaceutical purposes; medicinal roots; depuratives for the body; lecithin dietary supplements; medicines for human purposes in the treatment of nervous system disorders; medicated candy; lotions for pharmaceutical purposes in the treatment of dermatological conditions; magnesia for pharmaceutical purposes as an antacid and dietary supplement; medicated soap; mineral food supplements; vitamins; vitamin supplement patches; medicinal drinks; medicinal infusions for treating gastrointestinal disorders; herbal tinctures for medical purposes; nutraceutical preparations for therapeutic or medical purposes as a dietary supplement; fumigating sticks; fumigation preparations for medical purposes; medicinal oils; mouthwashes for medical purposes; headache relief sticks; antioxidant food supplement pills; by-products of the processing of cereals for medical purposes including as dietetic preparations adapted for medical use; nutritional supplements; preparations in the nature of sexual stimulants for increasing sexual prowess; human immune globulin for use in autoimmune medical treatments; therapeutic drugs and agents for weight control and appetite suppression; pre-filled syringes for medical purposes sold filled with insulin; bath preparations for medical purposes; dietary supplements for animals; pharmaceutical preparations for the treatment and prevention of influenza; opotherapy preparations; preparations of trace elements in the nature of dietary and nutritional supplements for human and animal use; medicated toiletry preparations; freezedried food adapted for medical purposes; protein dietary supplements; soy protein dietary supplements; antivirals; antiarrhythmic drugs; anti-inflammatories; antiepileptic drugs; antitumor drugs; sedatives; tissues impregnated with pharmaceutical skin lotions; syrups for pharmaceutical purposes for treatment of cough and cold; medicated salts for mineral water baths; mineral water salts for medical purposes; vegan protein for use as a nutritional supplement in ready-to-drink beverages; cough pastilles for pharmaceutical purposes; therapeutic preparations for the bath; thermal watervitamin and mineral enriched water for medical purposes; tonicsmedicines for use in the treatment of cardiovascular diseases; medicinal herbs; pharmaceuticalsantihelminticspsychotropics; pharmaceutical substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesitycognitive disorders; ferments for pharmaceutical purposes; diarrhoea medication; phytotherapy preparations for medical purposes; dietary food supplements for medical purposes; medicated sweets; medicinal tea; asthmatic tea; herbal teas for medicinal purposes; medicated shampoos; medicated dry shampoo
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/02/2024
FIMP
FINAL DISPOSITION PROCESSED
01/02/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
31/01/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
31/10/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
31/10/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/09/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
16/08/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
16/08/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/08/2023
PUBO
PUBLISHED FOR OPPOSITION
15/08/2023
GPNX
NOTIFICATION PROCESSED BY IB
14/08/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
26/07/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
26/07/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/07/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/07/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
13/07/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
13/07/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
13/07/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
13/07/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/06/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/06/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/06/2023
RFNT
REFUSAL PROCESSED BY IB
09/01/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
16/12/2022
RFRR
REFUSAL PROCESSED BY MPU
16/12/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
13/09/2022
CNRT
NON-FINAL ACTION WRITTEN
12/09/2022
DOCK
ASSIGNED TO EXAMINER
06/09/2022
MAFR
APPLICATION FILING RECEIPT MAILED
15/03/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/03/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/03/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SEFIRA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.